New Breast Cancer Drug May Help Younger Women, Too

Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.
Source: WebMD Health - Category: Consumer Health News Source Type: news

Related Links:

The now published results from the EMBRACA study confirm that talazoparib prolongs progression-free survival in advanced BCRA-positive breast cancer.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
This article will present feasible weight loss interventions, and will discuss practical implications of ongoing chemotherapy and endocrine therapy with regard to weight gain, and the impact of obesity on therapy-related conditions during breast cancer survivorship.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
A chest wall recurrence of breast cancer following mastectomy is a complex clinical problem that can push centers to the limits of their resources.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news
Genomics and Health Disparities Lecture Series John Carpten, PhD is Professor and Chair for the Department of Translational Genomics. His training and professional experiences include postdoctoral training at the National Human Genome Research Institute/NIH, and serving as Deputy Director of Research at the Translational Genomics Research Institute (TGen). Dr. Carpten ’ cancer research program spans multiple disciplines including germline genetics for disease risk and predisposition, somatic cancer genomics, health disparities research, cell biology, functional genomics, and precision medicine. The primary focus of h...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
Conditions:   Invasive Breast Cancer;   Ipsilateral Recurrence;   Sentinel Lymph Node Biopsy Intervention:   Procedure: Sentinel LN in breast cancer recurrence Sponsors:   Institut Cancerologie de l'Ouest;   Direction Générale de l'Offre de Soins Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Breast Carcinoma;   Healthy Subject;   Malignant Soft Tissue Neoplasm;   Sarcoma;   Skin Carcinoma Intervention:   Procedure: Photoacoustic Imaging Sponsors:   Roswell Park Cancer Institute;   National Cancer Institute (NCI) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Breast Cancer Interventions:   Other: Evidence-based information;   Behavioral: Patient Decision Aid;   Other: Sham information Sponsors:   McMaster University;   Canadian Cancer Society Research Institute (CCSRI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Ra úl A. Mejía-Pedroza, Jesús Espinal-Enríquez, Enrique Hernández-Lemus
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
Conclusion: Our findings provide strong evidence that miR-9 and miR-221 can enhance the generation of cancer stem cells to yield an invasive phenotype and that overexpression of these miRNAs predicts a poor outcome for breast cancer patients.Cell Physiol Biochem 2018;48:2205 –2218
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
There are multiple stages of breast cancer, ranging from 0 –4. Each has it’s own particular set of symptoms and treatment possibilities. There are treatment options for each stage with varying outlooks for success depending on the stage and person. The earlier the stage, the more likely treatment will be successful.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Breast Cancer Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Health | Women